Skip to content
Open in App
Zhuhai Trinomab Pharmaceutical

Zhuhai Trinomab Pharmaceutical

web2

Zhuhai Trinomab Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, an...

Stage
Undisclosed
Funding
Undisclosed
Team
0
0.0Mission ScoreFixed 0-100 scale

About

Zhuhai Trinomab Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, and commercializes therapeutics for infectious diseases and pain-related or autoimmune disorders. The company’s product includes Siltartoxatug Injection (TNM002), a recombinant anti-tetanus toxin monoclonal antibody that neutralizes the toxic effects that target the human neural system. The company was founded in 2015 and is based in Zhuhai, China.

Expert Insight
Zhuhai Trinomab Pharmaceutical profile.

Expert Coverage

No published expert evaluations are available for this project yet.

PharmaceuticalsHealthcare
0team
0evaluations
0subscribers